Journal ArticleOPEN ACCESS

Summary of the BSR biological DMARD safety guidelines

  • Chaplin S
Prescriber (2019) 30(3) 34-37
DOI: 10.1002/psb.1749
N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The British Society for Rheumatology (BSR) recently published new evidence‐based guidelines on the safe prescribing of biological DMARDs for inflammatory arthritis. This article provides a summary of their recommendations on screening, monitoring and considering co‐morbidities prior to and during treatment.

Cite

CITATION STYLE

APA

Chaplin, S. (2019). Summary of the BSR biological DMARD safety guidelines. Prescriber, 30(3), 34–37. https://doi.org/10.1002/psb.1749

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free